Filing step-change
MAPROIN · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
MAPROIN made a standard shift in the morning trading session.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 70.87 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 70.87 % | 147.28 | ▼ |
Cite this
Source: Samhati filing step-change for MAPROIN (2026-10). Observation: MAPROIN made a standard shift in the morning trading session. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/maproin/q/2026-10
Other periods